Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Dolasetron mesilate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Anzemet 200mg tablets
0406000Z0BBABAB
|
Anzemet | Dolasetron mesilate | Central Nervous System | No data available |
|
Anzemet 50mg tablets
0406000Z0BBAAAA
|
Anzemet | Dolasetron mesilate | Central Nervous System | No data available |
|
Anzemet IV 100mg/5ml solution for injection ampoules
0406000Z0BBADAD
|
Anzemet | Dolasetron mesilate | Central Nervous System | No data available |
|
Anzemet IV 12.5mg/0.625ml solution for injection ampoules
0406000Z0BBACAC
|
Anzemet | Dolasetron mesilate | Central Nervous System | No data available |
|
Dolasetron 100mg/5ml solution for injection ampoules
0406000Z0AAADAD
|
Dolasetron mesilate | Dolasetron mesilate | Central Nervous System | No data available |
|
Dolasetron 12.5mg/0.625ml solution for injection ampoules
0406000Z0AAACAC
|
Dolasetron mesilate | Dolasetron mesilate | Central Nervous System | No data available |
|
Dolasetron 200mg tablets
0406000Z0AAABAB
|
Dolasetron mesilate | Dolasetron mesilate | Central Nervous System | No data available |
|
Dolasetron 50mg tablets
0406000Z0AAAAAA
|
Dolasetron mesilate | Dolasetron mesilate | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.